Enzymes Market Is Expected to Reach $5.4 Billion, Worldwide, by 2020 - Allied Market Research

According to a new report by Allied Market Research titled, "World Enzymes Market -Opportunity and Forecast, 2014-2020", world enzymes market is expected to register a CAGR of 7.8% during 2015-2020. The household care segment holds about 1/3rd of the overall market share in 2014, due to large consumption of varied enzymes in detergents industry.

Presently, enzymes are witnessing high demand in various industries such as biofuels, food & beverages and detergents. The growing popularity of enzymes for production of renewable fuels such as biodiesel, preference of enzymes for manufacturing mild detergents and rising adoption of enzymes in pharmaceutical formulations are the key factors fueling the market growth. In addition, growing use of feed enzymes in animal nutrition would further boost the market growth. However, high sensitivity of enzymes to temperature and pH and risk of contamination would limit the overall market growth.

To know more about the report, visit the website at https://www.alliedmarketresearch.com/enzymes-market

Carbohydrases enzymes segment held a dominant position in 2014 and would continue to lead over the forecast period. This is due to its wide range of applications in detergents and food & beverages industry for the degradation of carbohydrate rich compounds such as starch. However, polymerases & nucleases segment is projected to be the fastest growing segment owing to its growing utilization in biotechnology and pharmaceutical research. Based on reaction, Hydrolases enzyme segment dominated the market with around 77.9% market share in 2014. This is due to the large scale use of hydrolytic enzymes for the hydrolysis of carbohydrates and proteins. Based on source, microorganism derived enzymes was the leading revenue generating segment (due to its feasibility for large scale production and wide range of applications) in 2014, accounting for around 3/5th of the overall market.

Key findings of the study:

Pharma & biotech...